文献速递肿瘤 PET/CT

根治性前列腺切除术后生化复发患者行全身68Ga-PSMA-11 PET/CT时,排尿后延迟相腹盆腔PET/CT是否有诊断获益?

Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
PubMed 文献 · EJNMMI Res · 2022-03-04

该回顾性研究纳入根治性前列腺切除术后生化复发患者,在标准全身早期相68Ga-PSMA-11 PET/CT(注射后105±45分钟)基础上加做排尿后延迟相腹盆腔PET/CT(注射后159±13分钟)。早期相全身PET/CT在33例患者中检出93个前列腺癌病灶,延迟相在2例患者中额外检出2个病灶,均为局部复发。淋巴结转移延迟相SUVmax由14.5±11.6升至21.5±17.6(p=0.00007,+1.6倍),良性淋巴结由1.4±0.5升至1.7±0.5(p=0.0014,+1.2倍)。作者认为延迟相可能有助于检出标准全身显像漏诊的局部复发,双时相显像可能有助于区分恶性与良性淋巴结。

要点

  • 延迟相腹盆腔PET/CT在2例患者中额外检出2个病灶,均为局部复发。
  • 淋巴结转移延迟相SUVmax由14.5±11.6升至21.5±17.6(p=0.00007,+1.6倍)。
  • 良性淋巴结延迟相SUVmax由1.4±0.5升至1.7±0.5(p=0.0014,+1.2倍)。

核心结论

  • 作者认为,根治性前列腺切除术后生化复发患者排尿后加做腹盆腔延迟相68Ga-PSMA-11 PET/CT可能有助于检出标准全身68Ga-PSMA-11 PET/CT漏诊的局部复发。
  • 作者认为,淋巴结转移在延迟相PET/CT上SUVmax更高且升高幅度大于良性淋巴结,双时相68Ga-PSMA-11 PET/CT可能有助于区分恶性与良性淋巴结。
  • 作者指出,骨转移尤其是局部复发在延迟相也表现出代谢随时间升高。

研究设计与样本

  • 该研究为回顾性研究,纳入根治性前列腺切除术后生化复发患者。
  • 患者行标准全身早期相PET/CT(注射后105±45分钟)及额外延迟相PET/CT(注射后159±13分钟)。
  • 延迟相PET/CT覆盖肝下缘至大腿上段,于患者如厕排空膀胱后进行。
  • 参考标准为组织病理学和/或随访影像。

主要发现

  • 早期相全身PET/CT在33例患者中检出93个前列腺癌病灶。
  • 延迟相PET/CT在2例患者中额外检出2个病灶,均为局部复发。
  • 全部病灶包括57个淋巴结转移、28个骨转移、3个肺转移和7个局部复发。
  • 淋巴结转移早期相与延迟相SUVmax分别为14.5±11.6与21.5±17.6(p=0.00007),延迟相为早期相的+1.6倍。
  • 相应区域良性淋巴结早期相与延迟相SUVmax分别为1.4±0.5与1.7±0.5(p=0.0014),延迟相为早期相的+1.2倍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To assess the diagnostic value of an additional late-phase PET/CT scan after urination as part of 68 Ga-PSMA-11 PET/CT for the restaging of patients with biochemically recurrent prostate cancer (BCR). METHODS: This retrospective trial included patients with BCR following radical prostatectomy, who underwent standard whole-body early-phase PET/CT performed 105 ± 45 min and an additional late-phase PET/CT performed 159 ± 13 min after injection of 68 Ga-PSMA-11. Late-phase PET/CT covered a body volume from below the liver to the upper thighs and was conducted after patients had used the bathroom to empty their urinary bladder. Early- and late-phase images were evaluated regarding lesion count, type, localisation, and SUVmax. Reference standard was histopathology and/or follow-up imaging. RESULTS: Whole-body early-phase PET/CT detected 93 prostate cancer lesions in 33 patients. Late-phase PET/CT detected two additional lesions in two patients, both local recurrences. In total, there were 57 nodal, 28 bone, and 3 lung metastases, and 7 local recurrences. Between early- and late-phase PET/CT, lymph node metastases showed a significant increase of SUVmax from 14.5 ± 11.6 to 21.5 ± 17.6 (p = 0.00007), translating to a factor of + 1.6. Benign lymph nodes in the respective regions showed a significantly lower increase of SUVmax of 1.4 ± 0.5 to 1.7 ± 0.5 (p = 0.0014, factor of + 1.2). Local recurrences and bone metastases had a SUVmax on late-phase PET/CT that was + 1.7 and + 1.1 times higher than the SUVmax on early-phase PET/CT, respectively. CONCLUSION: In patients with BCR following radical prostatectomy, an additional abdomino-pelvic late-phase 68 Ga-PSMA-11 PET/CT scan performed after emptying the urinary bladder may help to detect local recurrences missed on standard whole-body 68 Ga-PSMA-11 PET/CT. Lymph node metastases show a higher SUVmax and a stronger increase of SUVmax than benign lymph nodes on late-phase PET/CT, hence, biphasic 68 Ga-PSMA-11 PET/CT might help to distinguish between malignant and benign nodes. Bone metastases, and especially local recurrences, also demonstrate a metabolic increase over time.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Morawitz J, Kirchner J, Hertelendy J, et al. Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy? EJNMMI Res. 2022. PMID: 35244791. doi:10.1186/s13550-022-00885-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。